Syngene International Limited (NSE:SYNGENE) — Market Cap & Net Worth
Market Cap & Net Worth: Syngene International Limited (SYNGENE)
Syngene International Limited (NSE:SYNGENE) has a market capitalization of $2.03 Billion (Rs187.86 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #6194 globally and #271 in its home market, demonstrating a 7.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Syngene International Limited's stock price Rs467.65 by its total outstanding shares 401715908 (401.72 Million). Analyse SYNGENE cash generation efficiency to see how efficiently the company converts income to cash.
Syngene International Limited Market Cap History: 2015 to 2026
Syngene International Limited's market capitalization history from 2015 to 2026. Data shows growth from $894.51 Million to $2.03 Billion (9.21% CAGR).
Index Memberships
Syngene International Limited is a constituent of 5 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.11 Trillion | 0.07% | #245 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$102.93 Billion | 1.97% | #12 of 20 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$695.80 Billion | 0.29% | #108 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.11 Trillion | 0.18% | #159 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.06% | #242 of 750 |
Weight: Syngene International Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Syngene International Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Syngene International Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
Syngene International Limited's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.57x
Syngene International Limited's market cap is 0.57 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.21 Billion | $11.07 Billion | $2.41 Billion | 0.11x | 0.50x |
| 2017 | $1.17 Billion | $12.01 Billion | $2.87 Billion | 0.10x | 0.41x |
| 2018 | $1.21 Billion | $14.23 Billion | $3.05 Billion | 0.09x | 0.40x |
| 2019 | $1.39 Billion | $18.26 Billion | $3.32 Billion | 0.08x | 0.42x |
| 2020 | $2.77 Billion | $20.12 Billion | $4.12 Billion | 0.14x | 0.67x |
| 2021 | $2.68 Billion | $21.84 Billion | $4.05 Billion | 0.12x | 0.66x |
| 2022 | $2.54 Billion | $26.04 Billion | $3.96 Billion | 0.10x | 0.64x |
| 2023 | $3.04 Billion | $31.93 Billion | $4.64 Billion | 0.10x | 0.66x |
| 2024 | $3.73 Billion | $34.89 Billion | $5.10 Billion | 0.11x | 0.73x |
| 2025 | $2.83 Billion | $36.42 Billion | $4.96 Billion | 0.08x | 0.57x |
Competitor Companies of SYNGENE by Market Capitalization
Companies near Syngene International Limited in the global market cap rankings as of May 4, 2026.
Key companies related to Syngene International Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Syngene International Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Syngene International Limited's market cap moved from $894.51 Million to $ 2.03 Billion, with a yearly change of 9.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs2.03 Billion | -28.16% |
| 2025 | Rs2.83 Billion | -24.17% |
| 2024 | Rs3.73 Billion | +22.60% |
| 2023 | Rs3.04 Billion | +19.91% |
| 2022 | Rs2.54 Billion | -5.46% |
| 2021 | Rs2.68 Billion | -3.08% |
| 2020 | Rs2.77 Billion | +99.78% |
| 2019 | Rs1.39 Billion | +14.48% |
| 2018 | Rs1.21 Billion | +3.66% |
| 2017 | Rs1.17 Billion | -3.45% |
| 2016 | Rs1.21 Billion | +35.23% |
| 2015 | Rs894.51 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Syngene International Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.03 Billion USD |
| MoneyControl | $2.03 Billion USD |
| MarketWatch | $2.03 Billion USD |
| marketcap.company | $2.03 Billion USD |
| Reuters | $2.03 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more